기사

(Photo courtesy of Prodizen)

[Medical Today, Reporter Kim Ju-seong] Prodizen, a company specializing in cell therapy, is partnering with Honesty Plastic Surgery Clinic to incorporate insights from clinical practice into product development and academic research.

Prodizen announced on the 26th that it had signed a strategic memorandum of understanding (MOU) with Honesty Plastic Surgery Clinic on the 23rd, designating the clinic as a clinical partner. Under the agreement, the company plans to work with Dr. Jung Dong-woo, who serves as Prodizen’s Key Doctor, on product development consultation, joint skin research, and academic activities in Korea and abroad.

The partnership focuses on translating needs identified in clinical practice into specific development and research projects. Drawing on their experience in dermatology and aesthetic medicine, Dr. Jung and the clinic’s medical staff will recommend product features and areas for improvement. Prodizen will conduct technical reviews and provide development resources to help incorporate these recommendations into its R&D process.

Medical staff and product developers will exchange ideas from the product planning stage and agree on objectives and responsibilities for each project. They will continue sharing clinical feedback throughout development to create products that address practical needs and offer greater ease of use.

Joint skin research is another key priority. The two organizations plan to identify research topics together and develop their findings into journal articles and conference presentations. They will also collaborate on participation in Korean and international conferences and the preparation of presentations, expanding opportunities to share their research experience and findings with medical professionals.

Dr. Jung will provide clinical advice and participate in academic exchanges. Prodizen plans to create opportunities for physicians across various specialties to exchange views and explore new collaborative projects based on their respective clinical experience.

Through this designation, Prodizen intends to expand its collaboration with medical institutions across product development and research, while maintaining a framework for ongoing dialogue.

“The needs and suggestions for improvement that medical professionals identify in clinical practice are an important starting point for product development,” said Shim Soo-ja, CEO of Prodizen. “Through our collaboration with Dr. Jung Dong-woo, we will translate clinical feedback into specific development projects and support sustained joint research and academic exchange.”

Medical Today, Reporter Kim Ju-seong (kimchu7189@mdtoday.co.kr)

Source: Medical Today